Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”

Detalles Bibliográficos
Autores principales: Takada, Kazuki, Takamori, Shinkichi, Miura, Naoko, Shikada, Yasunori, Shimokawa, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629511/
https://www.ncbi.nlm.nih.gov/pubmed/34870248
http://dx.doi.org/10.1016/j.jtocrr.2021.100238
_version_ 1784607221458403328
author Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
author_facet Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
author_sort Takada, Kazuki
collection PubMed
description
format Online
Article
Text
id pubmed-8629511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86295112021-11-30 Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors” Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu JTO Clin Res Rep Letter to the Editor Elsevier 2021-11-29 /pmc/articles/PMC8629511/ /pubmed/34870248 http://dx.doi.org/10.1016/j.jtocrr.2021.100238 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_full Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_fullStr Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_full_unstemmed Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_short Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_sort correspondence regarding “tolerability of coronavirus disease 2019 vaccines bnt162b2 and mrna-1273 in patients with thymic epithelial tumors”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629511/
https://www.ncbi.nlm.nih.gov/pubmed/34870248
http://dx.doi.org/10.1016/j.jtocrr.2021.100238
work_keys_str_mv AT takadakazuki correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT takamorishinkichi correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT miuranaoko correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT shikadayasunori correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT shimokawamototsugu correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors

Ejemplares similares